pancreas and glp 1 GLP-1 glp 1 drugs and pancreatitis

The Expert Committee observed that, Glucagon-like peptide-1 (GLP-1) receptor agonists can help people with type 2 diabetes especially those who also have heart or kidney disease by improving blood sugar control, reducing the risk of heart and kidney complications, supporting weight loss, and even lowering the risk of early death, WHO said in its official release

Nanoparticle-facilitated delivery of BAFF-R siRNA for B cell intervention and rheumatoid arthritis therapy

These medications include GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide, as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound)

Natural Science Foundation in Guangdong (2022A1515010582 to X.L)